← Back to Clinical Trials
Recruiting NCT06616857

NCT06616857 Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06616857
Status Recruiting
Phase
Sponsor Nemours Children's Clinic
Condition Cystic Fibrosis (CF)
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-02-18
Primary Completion 2026-07

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
NUDGEEducation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-02-18 with a primary completion date of 2026-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to help adolescents and young adults between the ages of 13-25 with Cystic Fibrosis (CF), medically stable, able to speak and read English, and are not experiencing a CF - related exacerbation, who are already active to remain, or gradually encourage them to increase their levels of physical activity Participants will be asked to utilize a smartphone program, called NUDGE that we have developed. NUDGE is a chatbot with evidence-based features known to help teens make progress toward health goal: * Set and review goals * Self-monitor progress * Provide feedback on goal attainment * Revise future goals

Eligibility Criteria

Inclusion Criteria: 1. 13-25 years old 2. Has a verified CF diagnosis or CF-related disorder 3. Medically stable (i.e., FEV1\>30%, not experiencing a CF-related exacerbation) 4. Speaks and reads English Exclusion Criteria: 1. Have a comorbidity limiting PA participation (e.g., neurological condition) 2. Have a significant cognitive impairment that interferes with study completion 3. Have any oxygen, CPAP or BiPAP requirement

Frequently Asked Questions

Who can join the NCT06616857 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, up to 25 Years, studying Cystic Fibrosis (CF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06616857 currently recruiting?

Yes, NCT06616857 is actively recruiting participants. Visit ClinicalTrials.gov or contact Nemours Children's Clinic to inquire about joining.

Where is the NCT06616857 trial being conducted?

This trial is being conducted at Jacksonville, United States.

Who is sponsoring the NCT06616857 clinical trial?

NCT06616857 is sponsored by Nemours Children's Clinic. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology